Siemens Healthineers (ETR:SHL) has been assigned a €40.00 ($47.06) price objective by analysts at Barclays in a research note issued on Wednesday, Borsen Zeitung reports. The firm presently has a “neutral” rating on the stock. Barclays‘s price objective points to a potential upside of 6.81% from the company’s current price.
A number of other brokerages have also issued reports on SHL. Nord/LB set a €52.00 ($61.18) target price on shares of Siemens Healthineers and gave the stock a “buy” rating in a research report on Tuesday, August 4th. Sanford C. Bernstein set a €47.00 ($55.29) target price on Siemens Healthineers and gave the company a “buy” rating in a research report on Monday. Royal Bank of Canada set a €45.00 ($52.94) price objective on shares of Siemens Healthineers and gave the stock a “neutral” rating in a report on Tuesday, July 21st. Deutsche Bank set a €40.00 ($47.06) target price on shares of Siemens Healthineers and gave the stock a “neutral” rating in a research note on Monday, August 3rd. Finally, Independent Research set a €39.00 ($45.88) target price on Siemens Healthineers and gave the stock a “neutral” rating in a research report on Friday, September 4th. Two research analysts have rated the stock with a sell rating, seven have assigned a hold rating and seven have issued a buy rating to the stock. Siemens Healthineers has an average rating of “Hold” and an average price target of €42.64 ($50.16).
Shares of Siemens Healthineers stock opened at €37.45 ($44.06) on Wednesday. Siemens Healthineers has a 1 year low of €28.50 ($33.53) and a 1 year high of €47.27 ($55.61). The company has a debt-to-equity ratio of 56.67, a current ratio of 1.31 and a quick ratio of 0.79. The business has a 50-day moving average of €39.13 and a two-hundred day moving average of €40.08. The company has a market capitalization of $37.43 billion and a P/E ratio of 25.34.
Siemens Healthineers AG develops, manufactures, and distributes imaging, advanced therapies, and diagnostic products and services to healthcare providers worldwide. It operates in three operating segments: Imaging, Advanced Therapies, and Diagnostics. The Imaging segment provides diagnostic imaging and ultrasound systems and solutions.
Recommended Story: Return on Equity (ROE)
Receive News & Ratings for Siemens Healthineers Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Siemens Healthineers and related companies with MarketBeat.com's FREE daily email newsletter.